EQT Partners launched a $654m takeover bid for Swedish pharmaceutical company, Karo Pharma. Karo Pharma is a specialty pharmaceutical company, which develops and markets products for pharmacies as well as directly to the healthcare sector. The Company was founded in 1987 and has been listed on Nasdaq Stockholm since 1998. ”The specialty pharmaceutical market will offer attractive growth opportunities going forward, both organically through introductions of new and innovative compounds to patients and inorganically through acquisitions, as a result of the continued consolidation of the pharmaceutical industry. We believe Karo Pharma is very well positioned to take advantage of this market opportunity and we are excited about the opportunity to support the company and its employees in this exciting journey”, said Åsa Riisberg, Partner at EQT Partners, Head of EQT’s global Healthcare Sector and Investment Advisor to EQT VIII.